Frederick Sundram
Associate Professor and Deputy Head of the Department of Psychological Medicine at the University of Auckland
Data updated
Research Footprint
Frederick Sundram appears in 8 tracked papers (2020–2026), most studied alongside LSD, Ketamine and MDMA, across Depressive Disorders, Major Depressive Disorder (MDD) and Microdosing.
Most-cited paper: A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties (65 citations).
Frequent co-authors: Suresh Muthukumaraswamy, Rebecca Sumner and Anna Forsyth.
Background & Research
Frederick Sundram is an Associate Professor in the Department of Psychological Medicine at the University of Auckland and serves as Deputy Head of Department. His work spans mood disorders, psychopharmacology, and consultation-liaison psychiatry, and he appears as a co-author on multiple studies involving LSD microdosing, ketamine, and psychedelic-assisted therapy perceptions. He is also affiliated with the University of Auckland’s Centre for Addiction Research.
Key Impact
He is a psychiatrist and clinical researcher contributing to psychedelic and novel-antidepressant studies, including LSD microdosing and ketamine/depression research.
Collaboration Network
7 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Frederick Sundram is associated with.